Researchers have been exploring a non-invasive brain treatment called intranasal-transcranial photobiomodulation (itPBM), which uses near-infrared light to stimulate brain activity. This technology has been studied for its potential benefits in various areas, including traumatic brain injury (TBI), cognitive impairment, and symptoms related to Long COVID. Independent research teams from respected institutions like the University of Toronto and UCLA have conducted trials to assess how itPBM affects brain function and health.

For those interested in healthy aging, these findings could be significant. The research indicates that itPBM may help improve cognitive function, mood, and even sleep quality, particularly in athletes and individuals recovering from brain injuries. A recent study involving NCAA football players showed that itPBM helped stabilize neuroinflammatory markers and improve cognitive outcomes over a competitive season. Additionally, a pilot trial on people experiencing Long COVID brain fog found that this approach was safe and feasible, suggesting it may have the potential to alleviate cognitive symptoms.

The current research is still in the early stages, with many studies being small or pilot trials. While the results are promising, they are not yet definitive. Larger studies are needed to confirm the benefits of itPBM in various populations, including military veterans and those with mild cognitive impairment. This technology is not yet FDA approved for treating neurological conditions, so while the findings are encouraging, they should be interpreted with caution.

If you’re curious about supporting your brain health, consider looking into lifestyle factors such as regular exercise, a balanced diet, and mental stimulation, which have strong evidence for promoting cognitive function as you age.

Source: globenewswire.com